HealthLeaders Media June 8, 2021
Alexandra Wilson Pecci

YiDing Yu, MD, chief medical officer at Olive, provides an overview of how AI is successfully being used in the revenue cycle.

Revenue cycle executives have a lot of conflicting thoughts about artificial intelligence (AI). They’re intrigued about it, but also sometimes confused and a bit skeptical. Not only do many vendors market tools like bots as AI, but even the experts struggle to provide real-world use cases illustrating how AI is being successfully used in the revenue cycle.

“Confusion and skepticism is incredibly natural, especially with newer technology,” says YiDing Yu, MD, chief medical officer at Olive, an artificial intelligence and process automation solution designed specifically for healthcare.

Dr. Yu is our guest on the new episode of the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Health System / Hospital, Interview / Q&A, Provider, RCM (Revenue Cycle Mgmt), Technology, Trends
Embracing the 'Musical Chairs:' How One VP of Rev Cycle Prioritizes Succession Planning
Remain Compliant – and Take the Money
The AI Blueprint: An Implementation Guide for Revenue Cycle Leaders
Tower Health says Ensemble Health Partners will take over billing, patient access management
BHB VALUE: Tackling Staffing and Reimbursement Challenges: The Role of AI-powered Automation in Successful Revenue Cycle Management

Share This Article